Related Experiment Video
Updated: Jan 15, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
COVID-19-related ARDS in a young infant with uncontrolled HIV after delay in EID
Farah A Falix1, Sylke J Nikkels2, Ginette M Ecury-Goossen3
1Department of pediatrics Curacao Medical Center, Willemstad, Curacao, Curaçao. farah.falix@cmc.cw.
Insights
Infants with HIV, especially those with delayed diagnosis, face severe COVID-19 risks. This case highlights the critical need for uninterrupted HIV prevention services during pandemics.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Public Health
Background:
- COVID-19 typically causes mild illness in children.
- Pediatric patients with primary immunodeficiency are at higher risk for severe COVID-19.
- Severe COVID-19 can be fatal in immunocompromised children.
Purpose of the Study:
- To report a case of severe COVID-19 in an infant with undiagnosed vertical HIV transmission.
- To emphasize the potential for delayed HIV diagnosis during the COVID-19 pandemic.
- To highlight the impact of pandemic-related barriers on HIV prevention services.
Main Methods:
- Case report of a 3.5-month-old infant with COVID-19-related acute respiratory failure.
- Infant diagnosed with vertical HIV transmission.
- Mother received antiretroviral therapy; infant received neonatal prophylaxis.
- Initial HIV screenings were negative; follow-up screening was planned.
Main Results:
- The infant presented with severe COVID-19 and acute respiratory failure.
- This is the first pediatric case of severe COVID-19 morbidity in an HIV-immunocompromised infant.
- Delayed diagnosis of vertical HIV transmission occurred despite antiretroviral exposure.
Conclusions:
- Awareness of delayed vertical HIV transmission diagnosis is crucial, even with prior antiretroviral exposure.
- COVID-19 pandemic barriers delayed HIV prevention, stressing the need for service continuity.
- This case underscores the severe risks of COVID-19 in immunocompromised infants with HIV.
Background:
COVID-19 has shown to cause generally mild disease in healthy children and adolescents. However, pediatric patients with primary immunodeficiency may develop severe and even fatal disease due to COVID-19.
Case Presentation:
We report the case of COVID-19-related acute respiratory failure in a 3.5-month-old infant with the diagnosis of vertical HIV transmission at disease presentation during the COVID-19 pandemic. The mother had received antiretroviral therapy from the third trimester of pregnancy and the infant had received dual neonatal prophylaxis. The first two postnatal HIV-RNA screenings immediately after birth and at the age of seven weeks were negative in this infant and follow-up screening had been planned at the age of 4 months.
Conclusions:
With the description of the disease presentation and clinical course, we intend to underscore awareness regarding the possibility of delayed diagnosis of vertical HIV transmission after previous antiretroviral drug exposure. We also demonstrate the delay in prevention of vertical transmission due to COVID-19 related pandemic barriers, which underscores the need for continuation of preventive services under all circumstances. Furthermore, this is the first pediatric report describing severe COVID-19 associated morbidity during immunocompromise caused by HIV.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Acute Respiratory Failure-IV